Clinical Trial

Molecular Characterisation of Colorectal Cancer Peritoneal Metastases

Study acronym: COLOMET II
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 1, 2025 (before its estimated July 3, 2025 completion). Its status may not reflect the trial's current state.
Summary
This project aims to characterise the tumour cell and tumour microenvironment of colorectal cancer peritoneal metastases, understand molecular changes leading to colorectal peritoneal metastasis, identify potential biomarkers and novel treatment strategies.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-08-22; most recent amendment 2024-12-31.
Status change: Not Yet Recruiting → Recruiting 2024-12-31
Trial Details
NCT Number NCT05513716
Lead Sponsor The Christie NHS Foundation Trust
Collaborators: University of Manchester
Conditions Colorectal Cancer Metastatic
Enrollment 200 participants
Start Date 2024-02-04
Primary Completion 2025-07-03 (estimated)
Study Completion 2025-07-03 (estimated)
Updated on ClinicalTrials.gov 2025-01-01